Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and

Sanjaya K Satapathy1, Jason M Vanatta, Ryan A Helmick

  • 11 Methodist University Hospital Transplant Institute, University of Tennessee Health Sciences Center, Memphis, TN. 2 Department of Internal Medicine, University of Tennessee Health Sciences Center, Memphis, TN. 3 School of Public Health, University of Memphis, Memphis, TN. 4 Department of Cardiology, Methodist University Hospital, University of Tennessee Health Sciences Center, Memphis, TN.

Transplantation
|January 19, 2017
PubMed

Insights

Coronary artery disease (CAD) does not impact liver transplant (LT) survival if revascularized. However, early postoperative cardiac events are linked to poorer survival in LT recipients.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation Medicine

Background:

  • Coronary artery disease (CAD) poses a significant challenge in liver transplantation (LT) evaluations.
  • Assessing the impact of CAD on post-LT survival is crucial for patient management.

Purpose of the Study:

  • To evaluate survival rates in liver transplant recipients based on the presence, severity, and extent of coronary artery disease.
  • To determine the influence of cardiac events within 90 days post-LT on patient survival.

Main Methods:

  • A study group of 87 LT recipients with pre-LT angiograms was compared to two control groups.
  • CAD was assessed using vessel and Reardon scoring systems.
  • Survival analysis was performed comparing groups with varying degrees of CAD and control cohorts.

Main Results:

  • Obstructive CAD (≥50% stenosis) was present in 33.3% of the study group, with 25.3% having multivessel disease.
  • No significant difference in post-LT survival was observed based on CAD severity, extent, or number of involved segments, provided revascularization was performed.
  • Patient survival in the revascularized CAD group was comparable to controls without obstructive CAD.

Conclusions:

  • Appropriate revascularization negates the negative impact of CAD severity or extent on post-LT survival.
  • Early postoperative cardiac events are independent predictors of inferior survival in LT recipients.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
615
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
616
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357